Company intelligence / Profile preview

Neo Medical

near Lausanne, Switzerlandneo-medical.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Clinical studies show that use of Neo Medical’s Force Control Technology™ in thoracolumbar fusion results in a threefold reduction in implant failure rates, a halving of infection risk, up to a 29% reduction in surgical time, and as much as a 58% reduction in revision surgeries. A recent post-market study found significant reductions in screw loosening rates and disability scores compared to standard care.

Therapeutic areas: Neurology
Modalities: Device (spinal implants and surgical platforms)Digital health (AI-driven augmented reality intraoperative data platform)
Industry: Implantable Medical Devices

Partnerships

Gyrus Capital SA (lead investor/partner); no major pharma or device company partnerships publicly disclosed as of June 2025.

Beyond the preview

Go deeper on Neo Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neo Medical.

Explore the full profile